Kathmere Capital Management LLC Makes New Investment in Upexi, Inc. $UPXI

Key Points

• Kathmere Capital Management LLC has acquired 2,192,983 shares of Upexi, Inc., valued at approximately $6.5 million, representing a 5.78% stake in the company.
• Analysts have issued optimistic ratings for Upexi, with a target price range between $15.00 and $15.50, indicating favorable outlook.
• Insider trading activity includes CEO Allan Marshall purchasing 161,943 shares, increasing his stake by 18.31%, and total insider ownership now stands at 4.42% of the company's stock.

Kathmere Capital Management LLC bought a new position in shares of Upexi, Inc. (NASDAQ:UPXI - Free Report) during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 2,192,983 shares of the company's stock, valued at approximately $6,535,000. Kathmere Capital Management LLC owned 5.78% of Upexi as of its most recent SEC filing.

Separately, North Star Investment Management Corp. acquired a new position in shares of Upexi during the second quarter worth approximately $45,000. 5.68% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

UPXI has been the topic of a number of research reports. Alliance Global Partners initiated coverage on Upexi in a research report on Monday, August 4th. They set a "buy" rating and a $15.00 target price on the stock. Cantor Fitzgerald raised Upexi to a "strong-buy" rating in a research report on Wednesday, August 13th. Finally, Wall Street Zen raised Upexi to a "hold" rating in a research report on Friday, May 30th. One research analyst has rated the stock with a Strong Buy rating and one has assigned a Buy rating to the company. Based on data from MarketBeat, the company has an average rating of "Strong Buy" and an average target price of $15.50.

Insider Activity at Upexi

In related news, CEO Allan Marshall purchased 161,943 shares of the stock in a transaction that occurred on Friday, July 11th. The stock was acquired at an average cost of $4.94 per share, with a total value of $799,998.42. Following the transaction, the chief executive officer owned 1,046,261 shares of the company's stock, valued at $5,168,529.34. This represents a 18.31% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Lawrence Dugan purchased 4,000 shares of the stock in a transaction that occurred on Tuesday, July 22nd. The stock was bought at an average cost of $7.50 per share, with a total value of $30,000.00. Following the completion of the transaction, the director directly owned 116,389 shares in the company, valued at $872,917.50. The trade was a 3.56% increase in their position. The disclosure for this purchase can be found here. In the last three months, insiders purchased 198,186 shares of company stock valued at $997,759. 4.42% of the stock is owned by insiders.

Upexi Price Performance

NASDAQ UPXI opened at $5.22 on Friday. The business has a fifty day simple moving average of $6.42 and a 200 day simple moving average of $6.80. Upexi, Inc. has a 12 month low of $1.90 and a 12 month high of $22.57.

Upexi Company Profile

Upexi, Inc manufactures and sells various branded products in the health, wellness, pet, beauty, and other markets. The company was formerly known as Grove, Inc and changed its name to Upexi, Inc in August 2022. The company was incorporated in 2018 and is headquartered in Clearwater, Florida.

Want to see what other hedge funds are holding UPXI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Upexi, Inc. (NASDAQ:UPXI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.